Voloridge Investment Management, LLC Legend Biotech Corp Transaction History

Voloridge Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$57.25 - $69.74 $7.32 Million - $8.92 Million	-127,843 Reduced 89.75%	14,595 $878,000
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $499,785 - $605,344	-7,913 Reduced 5.26%	142,438 $9.57 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $6.96 Million - $11.3 Million	150,351 New	150,351 $10.4 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $5.44 Million - $8.93 Million	-162,342 Reduced 74.46%	55,673 $3.06 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $1.3 Million - $2.02 Million	41,959 Added 23.83%	218,015 $7.92 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $3.07 Million - $4.25 Million	74,508 Added 73.37%	176,056 $8.21 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $507,616 - $726,850	14,376 Added 16.49%	101,548 $5.13 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $1.08 Million - $1.72 Million	41,903 Added 92.56%	87,172 $3.58 Million
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $1.07 Million - $1.47 Million	45,269 New	45,269 $1.31 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.